T&W Engineering

What T&W Engineering does

T&W Engineering is a Denmark-based health technology company founded in 2014 in Allerød, with stated capabilities across data science, ASIC development, and ear-EEG technology. Its ear-EEG technology is commercialized through Cebreo Medical A/S, headquartered at Borupvang 2, 3450 Lillerød, Denmark. The core product is NeuroBuds™, comfortable individualized in-ear earbuds that acquire medical-grade EEG and activity data continuously in natural environments. The hardware is paired with the Cebreo Monitoring Solution — a secure study and user management portal for real-time monitoring of data quality and participant adherence — and an AI-powered analytics platform that supports digital biomarker development across sleep, epilepsy, Parkinson's disease, Alzheimer's disease, and chronic pain.

The company targets clinical researchers, pharmaceutical companies, contract research organizations (CROs), and academic institutions conducting decentralized clinical trials. Named collaborations include Aarhus University (PANDA Parkinson's study), Odense University Hospital (sleep apnea / excessive daytime sleepiness), Pain Center South Denmark (chronic pain and insomnia), the InnoSleep research project, and the AHEAD Alzheimer's consortium. The go-to-market is enterprise field sales with a 'Book an Introduction' consultative CTA, supported by participation in major neurology, epilepsy, and sleep-medicine conferences across the US and Europe.

Revenue mechanics combine hardware sales or leasing of NeuroBuds devices with bundled professional services — site setup and training, device logistics, certified EEG annotations, digital biomarker strategy, protocol and study design input, advanced data analytics, and publication support. Pricing is not publicly disclosed; contracts are quote-based and enterprise-oriented. Operating status is active, with 11-50 employees and no disclosed funding rounds, revenue figures, or institutional investors in the provided data.

Name

T&W Engineering

Legal name

Cebreo Medical A/S

Website

https://tweng.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

T&W Engineering (commercialized through Cebreo Medical A/S) develops NeuroBuds™ in-ear EEG wearables and an AI-powered analytics platform for decentralized clinical trials, serving pharmaceutical companies, CROs, and academic researchers in sleep, epilepsy, and neurological disease studies.

Ownership category

akta.pro rank

Headquarters

HQ city

Allerød

HQ country

Denmark

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations

Revenue model

1. NeuroBuds Hardware and Monitoring Solution: Sale or lease of medical-grade in-ear EEG wearable devices (NeuroBuds) along with the Cebreo Monitoring Solution platform, which includes the study portal for real-time data quality and participant adherence monitoring. The company provides end-to-end support including device logistics, site setup, training, and data quality oversight as part of the solution delivery.
2. Clinical Trial Support Services: Scientific and operational support services across clinical trial phases — including digital biomarker strategy, protocol design input, certified EEG annotations, advanced data analytics, and publication support. This suggests professional services bundled with or sold alongside the hardware and platform subscription.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

T&W Engineering is a Danish health tech engineering services firm that delivers three core offerings: ear-EEG technology services (design and development support for in-ear EEG systems), ASIC development services (custom integrated circuit design for biomedical/health applications), and data-science services (applied analytics for biomedical signals). The company sells engineering expertise and design services to health technology clients rather than finished medical products under its own consumer brand.

Product overview

Cebreo Medical offers a unified platform for medical-grade EEG monitoring in natural environments. The core product is NeuroBuds™, comfortable in-ear wearable earbuds that collect continuous EEG and activity data. This hardware integrates with the AI-Powered Study and Analytics Platform and the associated Study and User Management Portal, all part of the broader Cebreo Monitoring Solution. Together, these products provide end-to-end capabilities spanning remote wearable data acquisition, real-time data quality monitoring, participant adherence tracking, and AI-powered analytics for digital biomarker development across sleep, epilepsy, and neurological conditions.

Differentiator

Problem solved

Functional benefit

Products and services

• Data-science services Applied data-science and analytics engineering services for biomedical and health-tech clients. Delivered to health technology organizations needing signal-processing, machine-learning, and analytical engineering capability they do not maintain in-house.
• ASIC development services Application-Specific Integrated Circuit (ASIC) design and development services for health-tech and biomedical applications. Delivered to organizations needing low-power, custom silicon for wearable and medical devices.
• Ear-EEG technology services Engineering services for ear-EEG technology, supporting design and development of in-ear EEG systems and related hardware. Targeted at medical device, neurotechnology, and biomedical research customers.

Quantifiable outcome

• Enables continuous, real-world EEG monitoring to capture neurophysiological dynamics marking progression in degenerative and neurological conditions over weeks or months
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Five partnerships are on record, tiered core.

• Aarhus University (AU)coreStrategic or Co-development PartnerCebreo Medical collaborates with Aarhus University on the PANDA project — a clinical study evaluating NeuroBuds for early detection of Parkinson's disease. The study involves longitudinal at-home acquisition of electrophysiological markers in patients with REM sleep behavior disorder (RBD) and Parkinson's disease, aiming to develop diagnostic and prognostic biomarkers.
• Odense University HospitalcoreStrategic or Co-development PartnerCebreo Medical partners with Odense University Hospital on a study evaluating NeuroBuds for day- and night EEG acquisition to explore the sleep-wake interplay and develop biomarkers for excessive daytime sleepiness in patients with sleep apnea. The study addresses residual daytime sleepiness symptoms that persist despite treatment.
• Pain Center South Denmark (Smertecenter Syd)coreStrategic or Co-development PartnerCebreo Medical collaborates with Pain Center South Denmark on a study evaluating NeuroBuds to measure the effect and interplay between Cognitive Behavioral Therapy for Insomnia (CBT-I) and EEG sleep parameters in patients with chronic pain and comorbid insomnia, aiming to develop a monitoring biomarker.
• InnoSleep (Research Project)coreStrategic or Co-development PartnerCebreo Medical partners with the InnoSleep research project, which focuses on evaluating NeuroBuds for at-home acquisition of electrophysiological markers related to sleep disorders and daytime sleepiness in patients with sleep apnea.
• AHEAD Study Consortium (Alzheimer's Disease Research)coreStrategic or Co-development PartnerCebreo Medical collaborates with the AHEAD study consortium on a project evaluating NeuroBuds for at-home acquisition of brain activity during sleep and navigation tasks to develop supportive diagnostic biomarkers for Alzheimer's disease — leveraging evidence that electrographic changes appear before clear clinical symptoms.

Scale indicators1 record

Recent moves4 records

Expansion highlights5 records

Direct peers

• IDUN Technologies: IDUN Technologies develops in-ear EEG sensors and earbud-form biosignal wearables. It is the most direct technical peer to Cebreo Medical's NeuroBuds given shared in-ear EEG capture approach and target markets in wellness, research, and clinical applications.
• BioSerenity: BioSerenity develops wearable EEG devices and connected services for neurology monitoring, including epilepsy and sleep, sold to hospitals and clinical research organizations. It overlaps with Cebreo on wearable EEG hardware and remote clinical trial support.
• Beacon Biosignals (formerly Dreem): Beacon Biosignals provides AI-powered EEG analytics for sleep and neurological disorders with a wearable headband, serving both clinical research and pharma. It is directly comparable to Cebreo as a sleep/neurology EEG analytics platform for decentralized trials.
• Cumulus Neuroscience: Cumulus Neuroscience offers an EEG-based platform for remote, at-home monitoring of brain function for clinical trials in neurology and psychiatry. It is one of the closest peers to Cebreo, competing for the same decentralized clinical trial customers with a similar wearables-plus-analytics value proposition.

Emerging players

• Muse (Interaxon): Muse sells consumer EEG headbands with meditation and sleep applications, and has explored clinical research extensions. It shares with Cebreo the wearable EEG-plus-software consumer/health positioning, though at a different price point and use case.
• Emotiv: Emotiv makes consumer and research-grade EEG headsets with cloud-based analytics, used in academic research, wellness, and emerging clinical applications. It overlaps with Cebreo at the EEG hardware and analytics layer for research customers.
• Elemind Technologies: Elemind builds non-invasive EEG wearable headbands for neurological conditions and is pursuing clinical applications in pain, sleep, and neurology. It intersects with Cebreo on wearable EEG form factor and clinical neuroscience indications.

Broad incumbents

• iRhythm Technologies: iRhythm's Zio wearable cardiac monitor combines a patch device, AI analytics, and clinical reporting services sold to physicians and health systems. The hardware-plus-AI-plus-service business model for ambulatory biosignal monitoring is directly analogous to Cebreo's play in EEG.
• Compumedics: Compumedics manufactures clinical EEG systems for sleep and neurology, including portable and ambulatory EEG, and supplies clinical research markets. It is an incumbent comparable to Cebreo in clinical/neurophysiology EEG hardware.
• Natus Medical: Natus is a long-standing clinical EEG hardware and software provider to hospitals and neurology clinics globally. It represents the incumbent scalp-EEG ecosystem that Cebreo's ear-EEG platform is positioned to disrupt or complement in decentralized settings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/tweng

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about T&W Engineering